Prognostic value of immune checkpoint molecules in breast cancer
文献类型：期刊论文
| 作者 | Fang, Jun1,2,4 ; Chen, Feng1,5; Liu, Dong1,2,4; Gu, Feiying1,2,4; Chen, Zhigang3; Wang, Yuezhen1,2,4
|
| 刊名 | BIOSCIENCE REPORTS
 |
| 出版日期 | 2020-07-07 |
| 卷号 | 40 |
| ISSN号 | 0144-8463 |
| DOI | 10.1042/BSR20201054 |
| 通讯作者 | Wang, Yuezhen(wangyuezhen_zch@126.com) |
| 英文摘要 | Immune checkpoint blockade treatments bring remarkable clinical benefits to fighting sev-eral solid malignancies. However, the efficacy of immune checkpoint blockade in breast cancer remains controversial. Several clinical trials of immune checkpoint blockades fo-cused on the effect of CTLA4 and PD1/PDL1 checkpoint inhibitors on breast cancer. Only a small portion of patients benefited from these therapies. Here we systematically investi-gated the expression of 50 immune checkpoint genes, including ADORA2A, LAG-3, TIM-3, PD1, PDL1, PDL2, CTLA-4, IDO1, B7-H3, B7-H4, CD244, BTLA, TIGIT, CD80, CD86, VISTA, CD28, ICOS, ICOSLG, HVEM, CD160, LIGHT, CD137, CD137L, OX40, CD70, CD27, CD40, CD40LG, LGALS9, GITRL, CEACAM1, CD47, SIRPA, DNAM1, CD155, 2B4, CD48, TMIGD2, HHLA2, BTN2A1, DC-SIGN, BTN2A2, BTN3A1, BTNL3, BTNL9, CD96, TDO, CD200 and CD200R, in different subtypes of breast cancer and assessed their prognostic value. The results showed that the expression patterns of these 50 immune checkpoint genes were distinct in breast cancer. High expression of B7-H3 mRNA was significantly associated with worse overall survival (OS), especially in patients with luminal A and luminal B breast cancer. The mRNA expression levels of TIM-3, ADORA2A, LAG3, CD86, CD80, PD1 and IDO1 had no relationship with OS in breast cancer. High expression levels of CTLA-4 and TIGIT were correlated with favorable prognosis in breast cancer. Interestingly, we observed that B7-H3 expression was negatively correlated with the efficacy of cyclophosphamide (CTX). In sum-mary, our study suggested that B7-H3 has potential prognostic value in breast cancer and is a promising target for immune therapy. |
| WOS关键词 | CTLA-4 BLOCKADE ; B7-H3 ; IPILIMUMAB ; INHIBITION ; EXPRESSION ; ANTIBODY |
| 资助项目 | Natural Science Foundation of Zhejiang province[LY19H160004] ; Bureau of Public Health of Zhejiang province[2017192527] |
| WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
| 语种 | 英语 |
| WOS记录号 | WOS:000558064800001 |
| 出版者 | PORTLAND PRESS LTD |
| 资助机构 | Natural Science Foundation of Zhejiang province ; Bureau of Public Health of Zhejiang province |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/70729]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Wang, Yuezhen |
| 作者单位 | 1.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou 310022, Zhejiang, Peoples R China 2.Key Lab Radiat Oncol Zhejiang Prov, Hangzhou 310022, Zhejiang, Peoples R China 3.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China 4.Univ Chinese Acad Sci, Dept Radiat Oncol, Zhejiang Canc Hosp, Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China 5.Univ Chinese Acad Sci, Inst Canc Res & Basic Med Sci, Chinese Acad Sci, Dept Breast Tumor Surg,Canc Hosp,Zhejiang Canc Ho, Hangzhou, Zhejiang, Peoples R China |
| 推荐引用方式 GB/T 7714 | Fang, Jun,Chen, Feng,Liu, Dong,et al. Prognostic value of immune checkpoint molecules in breast cancer[J]. BIOSCIENCE REPORTS,2020,40. |
| APA | Fang, Jun,Chen, Feng,Liu, Dong,Gu, Feiying,Chen, Zhigang,&Wang, Yuezhen.(2020).Prognostic value of immune checkpoint molecules in breast cancer.BIOSCIENCE REPORTS,40. |
| MLA | Fang, Jun,et al."Prognostic value of immune checkpoint molecules in breast cancer".BIOSCIENCE REPORTS 40(2020). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。